Clinical Trials Directory

Trials / Completed

CompletedNCT02196948

Electrolysis Percutaneous Therapeutic (EPTE) for Supraspinatus Tendinopathy

Electrolysis Percutaneous Therapeutic (EPTE) for the Management of Supraspinatus Tendinopathy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Universidad Rey Juan Carlos · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Therapeutic management of supraspinatus tendinopathy is conflicting. There is evidence that eccentric exercise protocols can be effective for this condition. The inclusion of other therapeutic modalities could help to the management of these patients. A new therapeutic approach, called Electrolysis Percutaneous Therapeutic (EPTE) has been clinically developed. The objective of this randomized clinical trial is to determine the effectiveness of the inclusion of EPTE into a eccentric exercise protocol for the management of patients with unilateral supraspinatus tendinopathy

Conditions

Interventions

TypeNameDescription
OTHERElectrolysis Percutaneous Therapeutic (EPTE)
OTHEREccentric exercise

Timeline

Start date
2014-07-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2014-07-22
Last updated
2014-12-03

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02196948. Inclusion in this directory is not an endorsement.